PMID: 9179771Jun 1, 1997Paper

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

Journal of Medical Virology
S D LeeA Safary

Abstract

The safety and immunogenicity of inactivated hepatitis A vaccine was evaluated in patients with chronic liver disease. Sixty hepatitis A virus antibody (anti-HAV) seronegative patients with chronic liver disease (56 chronic hepatitis B and four chronic hepatitis C) and from 17 to 47 years of age received a dose of 1440 ELISA units of the inactivated hepatitis A vaccine at month 0, and a booster at month 6. Anti-HAV seroconversion (> or = 33 mIU/mL) was 57.6% (34/59) on day 15, and reached 93.2% (55/59) 1 month after primary vaccination. At month 6, the seropositivity of anti-HAV decreased before the booster to 69.0% (40/58). All vaccinees had measurable titers of anti-HAV 1 month after booster vaccination, and were still seropositive at month 12. After initial vaccination, the geometric mean titers of anti-HAV among vaccine responders were 158, 264, 74, 1309, and 409 mIU/ml at day 15 and months 1, 6, 7, and 12. Overall, 59.7% (71/119) of the vaccine doses administered were followed by mostly minor reactions. The majority of symptoms reported were local, all of which resolved within 3 days after vaccination. No significant changes in serum liver enzyme levels were detected after vaccination. Thus, an inactivated hepatitis A vacc...Continue Reading

References

Aug 13, 1992·The New England Journal of Medicine·A WerzbergerG Calandra
May 15, 1989·Annals of Internal Medicine·E A Akriviadis, A G Redeker
Jan 1, 1986·Digestive Diseases and Sciences·J R Thornton, K W Heaton
Jan 1, 1986·Digestive Diseases and Sciences·J Y WangB N Chiang
Mar 1, 1982·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H C ThomasS Sherlock
Apr 1, 1993·Gastroenterology·S D LeeA Safary

❮ Previous
Next ❯

Citations

Jun 10, 1998·Lancet·R S Koff
Sep 12, 2013·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Stefano FagiuoliPierluigi Toniutto
Jan 9, 2001·Clinical Microbiology Reviews·J A Cuthbert
Jul 15, 2003·Clinical Microbiology Reviews·Andrea DuchiniPaul J Pockros
Nov 26, 1999·Alimentary Pharmacology & Therapeutics·S W Tsang, J J Sung
Jan 30, 2004·The New England Journal of Medicine·Allen S Craig, William Schaffner
Jul 7, 2009·The Medical Clinics of North America·Gaurav Mehta, Kenneth D Rothstein
Mar 10, 2001·Clinics in Liver Disease·A Regev, E R Schiff
Mar 10, 2001·Clinics in Liver Disease·M M Jonas
Apr 1, 2014·Journal of Epidemiology·Fuqiang CuiWeizhong Yang
Jun 28, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Anne MalfrootUNKNOWN European Cystic Fibrosis Society (ECFS) Vaccination Group
Dec 2, 2000·Journal of Gastroenterology and Hepatology·S D Lee
Jan 29, 2005·Arquivos De Gastroenterologia·Angelo Alves de MattosJosé Oscar dos Reis Remião
Jun 20, 2008·Expert Review of Vaccines·Hans Dieter Nothdurft
Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R P MyersP J Marotta
Jul 24, 2002·The American Journal of Gastroenterology·Kenneth D Rothstein
Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M H Sjogren
Aug 17, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael ShimEdmund J Bini
Sep 24, 2005·Pediatric Transplantation·Andrew L Campbell, Betsy C Herold
Jun 22, 2001·Journal of Clinical Gastroenterology·R S Koff
Jun 15, 2004·The Pediatric Infectious Disease Journal·Ewa Majda-StanislawskaJan Kuydowicz
Dec 6, 2001·The Pediatric Infectious Disease Journal·R GiacchinoL Romanò
Jul 3, 2020·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Noele P NelsonAaron M Harris
Jul 13, 2012·The Cochrane Database of Systematic Reviews·Greg J IrvingDaniel Pope
Nov 9, 2010·Southern Medical Journal·Manoj Kumar, Jorge L Herrera
Jul 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M Younossi, Maria Stepanova
Mar 15, 2019·Clinical Microbiology Reviews·Petra Zimmermann, Nigel Curtis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.